 |
|
| Blog results | Results 1 - 10 of about 29,697 for cancer clinical liver trial. (0.24 seconds) |
| Sorted by relevance Sort by date |
| 16 hours ago by Dr. NICK ... Texas) — The targeted agent sorafenib (Nexavar, Onyx/Bayer), currently approved for use in kidney and liver cancer, has shown activity in breast cancer in phase 2 clinical trials, and a large registration phase 3 trial is planned ... CANCER AND IMPORTANT MEDICAL NEWS - http://cancerology.blogspot.com/ [ More results from CANCER AND IMPORTANT MEDICAL NEWS ] |
| 1 May 2009 Free Online Library: CAN-FITE BIOPHARMA TO INITIATE CF102 TRIAL FOR LIVER CANCER. by "Worldwide Biotech"; Biotechnology industry Business Biological products industry Product development Clinical trials Liver cancer Care and treatment ... Advertising, marketing, public relations - http://www.thefreelibrary.com/ |
| 16 Dec 2009 Criteria for Participation in this Clinical Trial. Inclusion Criteria: 1. Resectable liver metastasis from colorectal cancer(the distance from the tumor lower edge to anal more than 12cm),no visible extrahepatic metastatic tumors. ... Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r... [ More results from Clinical Trials Updates During the Last 7 Days ] |
| 14 Dec 2009 by Kate Murphy During a phase II clinical trial in Germany and Austria, 111 patients with colorectal cancer that had spread to their liver were treated with Erbitux and either FOLFOX6 (oxaliplatin, fluorouracil, and leucovorin) or FOLFIRI (irinotecan, ... C3: Colorectal Cancer Coalition - http://fightcolorectalcancer.org/ - References [ More results from C3: Colorectal Cancer Coalition ] |
| 10 Dec 2009 by Nell Barrie To help overcome this hurdle, Cancer Research UK funds 20 childhood cancer clinical trial centres across Great Britain, linked together within the Children's Cancer and Leukaemia Group (CCLG). Our scientists also collaborate with ... Cancer Research UK - Science Update - http://scienceblog.cancerresearchuk.org/ - References [ More results from Cancer Research UK - Science Update ] |
| 14 Dec 2009 The findings presented were from a 110-patient Phase II trial assessing T-DM1 for the treatment of advanced (metastatic) HER2-positive breast cancer. To qualify for enrollment, patients must have undergone prior treatment with regimens ... One patient with pre-existing non-alcoholic fatty liver disease and multiple co-morbidities died from hepatic dysfunction. About ImmunoGen's Targeted Antibody Payload (TAP) Technology. The Company's TAP technology uses antibodies to ... Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html [ More results from Drugs.com - Clinical Trials ] |
| 18 Dec 2009 by Jennifer Marcus Celsion And Yakult Honsha Announce Treatment Of First Patient In Japan In Celsion's Global Phase III ThermoDox(R) Trial For Primary Liver Cancer. Posted by Jennifer Marcus | 18 December 2009, 2:28 pm ... By year-end 2009, Celsion expects to have up to sixty clinical sites activated and patient enrollment is expected to complete within the first half of 2010. Additional information can be found at: http://www.clinicaltrials.gov/. About Primary Liver Cancer ... zikkir - http://zikkir.com/health/ [ More results from zikkir ] |
| 9 Dec 2009 by admin ... treatment and supportive care of cancer and AIDS patients, today announces positive survival data in its phase II clinical trial with doxorubicin Transdrug® in patients with advanced hepatocellular carcinoma (primary liver cancer). ... NanoTechBIZZ.com - http://nanotechbizz.com/ - References |
| 2 Dec 2009 by Pharmasurgics Ab November 23rd, 2009 Pharmasset: hepatitis C drug trial will continueNEW YORK — Pharmasset Inc. said Monday that it will continue enrolling patients in a clinical trial of RG7128, a drug that is designed to treat the liver disease hepatitis C. ... November 16th, 2009 Poniard plunges on failure of picoplatin studyNEW YORK — Shares of Poniard Pharmaceuticals Inc. crashed Monday after the company said its cancer drug picoplatin missed its goal in a clinical trial. ... PR Hub - http://blog.taragana.com/pr/ - References [ More results from PR Hub ] |
| 15 Dec 2009 by Signs of the Times Among the herb's purported benefits is limiting liver toxicity from cancer chemotherapy, but this had not previously been tested in a placebo-controlled trial. So Kelly and colleagues assigned 50 children receiving treatment for ALL with a regimen of ... "Future clinical trials should explore milk thistle in the setting of patients in which hepatic toxicity prevents provision of the recommended chemotherapy in individuals with cancer," Kelly and colleagues concluded. ... Signs of the Times - http://www.sott.net/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
